Inventor · disambiguated record
Yi-Heng Chen
Also filed as: CHEN YI-HENG
18 granted patents·5 pending applications·137 citations·filing 2005–2024
92Inventor score
Top patents by PatentIndex Score
23 records- 0195US7652049B2CETP inhibitorsMERCK & CO INC·Filed 2005·Granted Jan 26, 2010·54 cites·54 claims
- 0294US7915271B21,3-oxazolidin-2-one derivatives useful as CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Mar 29, 2011·15 cites·21 claims
- 0392US7910592B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Mar 22, 2011·13 cites·15 claims
- 0489US7781426B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Aug 24, 2010·18 cites·12 claims
- 0587US9365574B2Soluble guanylate cyclase activatorsRAGHAVAN SUBHAREKHA·Filed 2011·Granted Jun 14, 2016·22 cites·17 claims
- 0686US9815846B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Nov 14, 2017·8 cites·16 claims
- 0780US10030027B2Soluble guanylate cyclase stimulatorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 24, 2018·3 cites·56 claims
- 0880US9221834B2Cyclic amine substituted oxazolidinone CETP inhibitorLU ZHIJIAN·Filed 2011·Granted Dec 29, 2015·3 cites·14 claims
- 0973US8440702B21,3-oxazolidin -2-one derivatives useful as CETP inhibitorsALI AMJAD·Filed 2011·Granted May 14, 2013·1 cites·21 claims
- 1070US2025326766A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1170US2024025912A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1265US2025154173A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1360US2014221383A1Cetp inhibitorsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1451US10428076B2Soluble guanylate cyclase stimulatorsMERCK SHARP & DOHME·Filed 2018·Granted Oct 1, 2019·0 cites·52 claims
- 1551US2016075724A1CETP InhibitorsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 1648US12319671B21-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 3, 2025·0 cites·16 claims
- 1747US9914727B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 13, 2018·0 cites·6 claims
- 1846US9708308B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·16 claims
- 1945US7935727B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted May 3, 2011·0 cites·17 claims
- 2041US9862716B2TRKA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·0 cites·16 claims
- 2140US10556900B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2016·Granted Feb 11, 2020·0 cites·11 claims
- 2240US10189819B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 29, 2019·0 cites·14 claims
- 2340US9695198B2Factor IXa inhibitorsSMITH CAMERON JAMES·Filed 2013·Granted Jul 4, 2017·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Yi-Heng Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →